BIOSANTE PHARMACEUTICALS

biosante-pharmaceuticals-logo

BioSante Pharmaceuticals, Inc. (BioSante) is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company's products for female sexual health, menopause, contraception and male hypogonadism include LibiGel, a once daily transdermal testosterone gel in Phase III clinical development under a special protocol assessment (SPA) for the treatment of female sexual dysfunction (FSD); Elestrin, a once daily transde... rmal estradiol (estrogen) gel indicated for the treatment of moderate-to-severe vasomotor symptoms; The Pill-Plus (triple component contraceptive), a once daily use of various combinations of estrogens, progestogens and androgens in development for the treatment of female sexual dysfunction (FSD) in women using oral or transdermal contraceptives, and Bio-T-Gel, a once daily transdermal testosterone gel in development for the treatment of hypogonadism, or testosterone deficiency, in men.

#SimilarOrganizations #People #Financial #Website #More

BIOSANTE PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1996-01-01

Address:
Lincolnshire, Illinois, United States

Country:
United States

Website Url:
http://www.biosantepharma.com

Total Employee:
11+

Status:
Active

Contact:
(847)478-0500

Email Addresses:
[email protected]

Total Funding:
18 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx Sitelinks Search Box Organization Schema


Similar Organizations

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

Current Employees Featured

not_available_image

Stephen M. Simes
Stephen M. Simes President and CEO @ BioSante Pharmaceuticals
President and CEO

Stock Details


Company's stock symbol is NASDAQ:BPAX

Investors List

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Post-IPO Equity - BioSante Pharmaceuticals

great-point-partners_image

Great Point Partners

Great Point Partners investment in Post-IPO Equity - BioSante Pharmaceuticals

Official Site Inspections

http://www.biosantepharma.com

  • Host name: 212-83-157-199.rev.poneytelecom.eu
  • IP address: 212.83.157.199
  • Location: Paris France
  • Latitude: 48.8543
  • Longitude: 2.3527
  • Timezone: Europe/Paris
  • Postal: 75015

Loading ...

More informations about "BioSante Pharmaceuticals" on Search Engine